BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/2/2014 5:02:00 PM | Browse: 1242 | Download: 1438
 |
Received |
|
2013-10-11 08:44 |
|
Peer-Review Started |
|
2013-10-15 08:31 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-10-30 10:09 |
|
Revised |
|
2013-11-15 10:39 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2013-12-13 14:02 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2013-12-13 14:57 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-02-12 12:02 |
|
Publish the Manuscript Online |
|
2014-03-12 11:24 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Immunotherapy in gastric cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Satoko Matsueda and David Y Graham |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Research Center for Innovative Cancer Therapy, Cancer Vaccine Development Division, Kurume University |
to Matsueda S |
| Office of Research and Development Medical Research Service Department of Veterans Affairs, Public Health Service (in part) |
DK067366 (to Graham DY) |
| Office of Research and Development Medical Research Service Department of Veterans Affairs, Public Health Service (in part) |
DK56338 (to Graham DY) |
|
| Corresponding Author |
David Y Graham, MD, Michael E DeBakey VA Medical Center, Baylor College of Medicine, 2002 Holcombe Blvd, Rm 3A-318B (111D), Houston, TX 77030, United States. dgraham@bcm.edu |
| Key Words |
Gastric cancer; Immune checkpoint; Immune escape; Adoptive cell therapy; Cancer vaccine; Antibody therapy; Predictive biomarker |
| Core Tip |
In the majority of cases gastric cancer is advanced at diagnosis and although medical and surgical treatments have improved, survival rates remain poor. Cancer immunotherapy has emerged as a powerful tool for cancer therapy and has recently shown major success in breast cancer, prostate cancer and melanoma. The field of cancer immunotherapy is in the midst of a huge transition due to the discovery of immunological networks and better understanding of the molecular mechanisms of immunosuppression in the cancer microenvironment. We discuss how immunotherapy will most likely play a major role in the cure of cancer. |
| Publish Date |
2014-03-12 11:24 |
| Citation |
Matsueda S, Graham DY. Immunotherapy in gastric cancer. World J Gastroenterol 2014; 20(7): 1657-1666
|
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i7/1657.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i7.1657 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
